October Pharma S.A.E (EGX:OCPH)

Market Cap	2.25B +74.6%
Revenue (ttm)	1.46B +22.5%
Net Income	165.09M +11.7%
EPS	13.76 +4.4%
Shares Out	12.00M
PE Ratio	13.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,191
Average Volume	4,396
Open	190.61
Previous Close	190.61
Day's Range	186.00 - 192.80
52-Week Range	90.02 - 249.88
Beta	0.15
RSI	38.09
Earnings Date	Apr 9, 2026

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides human medicines in the form of capsules, tablets, suppositories, syrup, and drops for internal and sprays and inhalers for external use. October Pharma S.A.E was incorporated in 1987 is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: OCPH

Financial Performance

In 2024, October Pharma S.A.E's revenue was 1.23 billion, an increase of 21.39% compared to the previous year's 1.01 billion. Earnings were 131.26 million, a decrease of -12.72%.